{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:27:29Z","timestamp":1778718449649,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-108-018"],"award-info":[{"award-number":["DMR-108-018"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC108B07"],"award-info":[{"award-number":["KMU-TC108B07"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW106-TDU-B-212-113004"],"award-info":[{"award-number":["MOHW106-TDU-B-212-113004"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In patients with chronic hepatitis C (CHC), the effects of baseline characteristics, virological profiles, and therapeutic outcome to pegylated interferon plus ribavirin (PR) therapy on autoimmune diseases are unknown. Taiwanese Chronic Hepatitis C Cohort is a nationwide hepatitis C virus registry cohort comprising 23 hospitals of Taiwan. A total of 12,770 CHC patients receiving PR therapy for at least 4 weeks between January 2003 and December 2015 were enrolled and their data were linked to the Taiwan National Health Insurance Research Database for studying the development of 10 autoimmune diseases. The mean follow-up duration was 5.3\u2009\u00b1\u20092.9 years with a total of 67,930 person-years, and the annual incidence of systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) was 0.03%. Other autoimmune diseases were not assessable due to few events. Body mass index \u226524\u2009kg\/m<jats:sup>2<\/jats:sup> was an independent predictor of the low incidence of SLE or RA (hazard ratio 0.40, 95% confidence interval 0.17\u20130.93, p\u2009=\u20090.034). A sustained virological response (SVR) to PR therapy was not associated with the low incidence of SLE or RA in any subgroup analysis. CHC patients achieving SVR to PR therapy did not exhibit an impact on the incidence of SLE or RA compared with non-SVR patients.<\/jats:p>","DOI":"10.1038\/s41598-020-61991-3","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T11:03:32Z","timestamp":1585134212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0738-417X","authenticated-orcid":false,"given":"Wei-Fan","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chih","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsueh-Chou","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Tao","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Hung","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui-Yi","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Houng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyh-Jou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Lun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-3190","authenticated-orcid":false,"given":"Chun-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chieh","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gin-Ho","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ming","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-7952","authenticated-orcid":false,"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8082-7144","authenticated-orcid":false,"given":"Chun-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-9707","authenticated-orcid":false,"given":"Chen-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jong","family":"Bair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hsin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chu","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-9018","authenticated-orcid":false,"given":"Pin-Nan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Cheng","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Shiung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Lun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-5425","authenticated-orcid":false,"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Chien","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Fu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Yen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Long","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-1900","authenticated-orcid":false,"given":"Ming-Lung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-6086","authenticated-orcid":false,"given":"Cheng-Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"61991_CR1","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1053\/jhep.2002.37191","volume":"36","author":"HB El-Serag","year":"2002","unstructured":"El-Serag, H. B., Hampel, H., Yeh, C. & Rabeneck, L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36, 1439\u20131445, https:\/\/doi.org\/10.1053\/jhep.2002.37191 (2002).","journal-title":"Hepatology"},{"key":"61991_CR2","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10##2204::AID-ANR24$$3.0.CO;2-D","volume":"42","author":"P Cacoub","year":"1999","unstructured":"Cacoub, P. et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 42, 2204\u20132212, https:\/\/doi.org\/10.1002\/1529-0131(199910)42:10##2204::AID-ANR24$$3.0.CO;2-D (1999).","journal-title":"Arthritis Rheum"},{"key":"61991_CR3","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.cgh.2010.08.026","volume":"8","author":"IM Jacobson","year":"2010","unstructured":"Jacobson, I. M., Cacoub, P., Dal Maso, L., Harrison, S. A. & Younossi, Z. M. Manifestations of chronic hepatitis C virus infection beyond the liver. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 8, 1017\u20131029, https:\/\/doi.org\/10.1016\/j.cgh.2010.08.026 (2010).","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"key":"61991_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/gutjnl-2014-308163","volume":"64","author":"YC Hsu","year":"2015","unstructured":"Hsu, Y. C. et al. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut 64, 495\u2013503, https:\/\/doi.org\/10.1136\/gutjnl-2014-308163 (2015).","journal-title":"Gut"},{"key":"61991_CR5","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/cid\/ciy585","volume":"67","author":"A-IHG Panel","year":"2018","unstructured":"Panel, A.-I. H. G. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis 67, 1477\u20131492, https:\/\/doi.org\/10.1093\/cid\/ciy585 (2018).","journal-title":"Clin Infect Dis"},{"key":"61991_CR6","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. Electronic address, e. e. e. & European Association for the Study of the, L. EASL Recommendations on Treatment of Hepatitis C 2018. Journal of hepatology 69, 461\u2013511, https:\/\/doi.org\/10.1016\/j.jhep.2018.03.026 (2018).","DOI":"10.1016\/j.jhep.2018.03.026"},{"key":"61991_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00002281-200007000-00011","volume":"12","author":"D Buskila","year":"2000","unstructured":"Buskila, D. Hepatitis C-associated arthritis. Curr Opin Rheumatol 12, 295\u2013299, https:\/\/doi.org\/10.1097\/00002281-200007000-00011 (2000).","journal-title":"Curr Opin Rheumatol"},{"key":"61991_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1517\/14656566.6.1.27","volume":"6","author":"C Palazzi","year":"2005","unstructured":"Palazzi, C., Olivieri, I., Cacciatore, P., Pennese, E. & D\u2019Amico, E. Management of hepatitis C virus-related arthritis. Expert Opin Pharmacother 6, 27\u201334, https:\/\/doi.org\/10.1517\/14656566.6.1.27 (2005).","journal-title":"Expert Opin Pharmacother"},{"key":"61991_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jbspin.2006.05.005","volume":"73","author":"C Lormeau","year":"2006","unstructured":"Lormeau, C., Falgarone, G., Roulot, D. & Boissier, M. C. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73, 633\u2013638, https:\/\/doi.org\/10.1016\/j.jbspin.2006.05.005 (2006).","journal-title":"Joint Bone Spine"},{"key":"61991_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10620-006-9510-9","volume":"52","author":"MP Dore","year":"2007","unstructured":"Dore, M. P., Fattovich, G., Sepulveda, A. R. & Realdi, G. Cryoglobulinemia related to hepatitis C virus infection. Dig. Dis. Sci. 52, 897\u2013907, https:\/\/doi.org\/10.1007\/s10620-006-9510-9 (2007).","journal-title":"Dig. Dis. Sci."},{"key":"61991_CR11","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1002\/1529-0131(200012)43:12##2801::AID-ANR21$$3.0.CO;2-V","volume":"43","author":"M Ramos-Casals","year":"2000","unstructured":"Ramos-Casals, M. et al. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis and rheumatism 43, 2801\u20132806, https:\/\/doi.org\/10.1002\/1529-0131(200012)43:12##2801::AID-ANR21$$3.0.CO;2-V (2000).","journal-title":"Arthritis and rheumatism"},{"key":"61991_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00000441-200605000-00003","volume":"331","author":"MM Ahmed","year":"2006","unstructured":"Ahmed, M. M. et al. Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus. The American journal of the medical sciences 331, 252\u2013256, https:\/\/doi.org\/10.1097\/00000441-200605000-00003 (2006).","journal-title":"The American journal of the medical sciences"},{"issue":"Suppl 1","key":"61991_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/s0168-8278(99)80372-9","volume":"31","author":"MP Manns","year":"1999","unstructured":"Manns, M. P. & Rambusch, E. G. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J. Hepatol. 31(Suppl 1), 39\u201342, https:\/\/doi.org\/10.1016\/s0168-8278(99)80372-9 (1999).","journal-title":"J. Hepatol."},{"key":"61991_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","volume":"80","author":"K Machida","year":"2006","unstructured":"Machida, K. et al. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 80, 866\u2013874, https:\/\/doi.org\/10.1128\/JVI.80.2.866-874.2006 (2006).","journal-title":"J Virol"},{"key":"61991_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","volume":"59","author":"J Peveling-Oberhag","year":"2013","unstructured":"Peveling-Oberhag, J., Arcaini, L., Hansmann, M. L. & Zeuzem, S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. Journal of hepatology 59, 169\u2013177, https:\/\/doi.org\/10.1016\/j.jhep.2013.03.018 (2013).","journal-title":"Journal of hepatology"},{"key":"61991_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 282, 938\u2013941, https:\/\/doi.org\/10.1126\/science.282.5390.938 (1998).","journal-title":"Science"},{"key":"61991_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-2000-9613","volume":"20","author":"F Dammacco","year":"2000","unstructured":"Dammacco, F. et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Seminars in liver disease 20, 143\u2013157, https:\/\/doi.org\/10.1055\/s-2000-9613 (2000).","journal-title":"Seminars in liver disease"},{"key":"61991_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.semarthrit.2013.06.001","volume":"43","author":"LC See","year":"2013","unstructured":"See, L. C., Kuo, C. F., Chou, I. J., Chiou, M. J. & Yu, K. H. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum 43, 381\u2013386, https:\/\/doi.org\/10.1016\/j.semarthrit.2013.06.001 (2013).","journal-title":"Semin Arthritis Rheum"},{"key":"61991_CR19","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/archinte.165.14.1624","volume":"165","author":"A Escalante","year":"2005","unstructured":"Escalante, A., Haas, R. W. & del Rincon, I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 165, 1624\u20131629, https:\/\/doi.org\/10.1001\/archinte.165.14.1624 (2005).","journal-title":"Arch Intern Med"},{"key":"61991_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.arcmed.2015.09.005","volume":"46","author":"HM Li","year":"2015","unstructured":"Li, H. M. et al. Plasma\/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis. Arch. Med. Res. 46, 551\u2013556, https:\/\/doi.org\/10.1016\/j.arcmed.2015.09.005 (2015).","journal-title":"Arch. Med. Res."},{"key":"61991_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3899\/jrheum.090790","volume":"37","author":"DA Landau","year":"2010","unstructured":"Landau, D. A. et al. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy. The Journal of rheumatology 37, 615\u2013621, https:\/\/doi.org\/10.3899\/jrheum.090790 (2010).","journal-title":"The Journal of rheumatology"},{"key":"61991_CR22","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","volume":"150","author":"Z Younossi","year":"2016","unstructured":"Younossi, Z., Park, H., Henry, L., Adeyemi, A. & Stepanova, M. Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden. Gastroenterology 150, 1599\u20131608, https:\/\/doi.org\/10.1053\/j.gastro.2016.02.039 (2016).","journal-title":"Gastroenterology"},{"key":"61991_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.md.0000157397.30055.c9","volume":"84","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals, M. et al. Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84, 81\u201389, https:\/\/doi.org\/10.1097\/01.md.0000157397.30055.c9 (2005).","journal-title":"Medicine (Baltimore)"},{"key":"61991_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","volume":"79","author":"P Cacoub","year":"2000","unstructured":"Cacoub, P. et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d\u2019Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l\u2019Hepatite C. Medicine (Baltimore) 79, 47\u201356, https:\/\/doi.org\/10.1097\/00005792-200001000-00005 (2000).","journal-title":"Medicine (Baltimore)"},{"key":"61991_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-o","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer, P. J. Classification of chronic viral hepatitis: a need for reassessment. Journal of hepatology 13, 372\u2013374, https:\/\/doi.org\/10.1016\/0168-8278(91)90084-o (1991).","journal-title":"Journal of hepatology"},{"key":"61991_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Castera","year":"2005","unstructured":"Castera, L. et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128, 343\u2013350, https:\/\/doi.org\/10.1053\/j.gastro.2004.11.018 (2005).","journal-title":"Gastroenterology"},{"key":"61991_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.kjms.2016.05.008","volume":"32","author":"YH Lin","year":"2016","unstructured":"Lin, Y. H. et al. The performance of acoustic radiation force impulse imaging in predicting liver fibrosis in chronic liver diseases. The Kaohsiung journal of medical sciences 32, 362\u2013366, https:\/\/doi.org\/10.1016\/j.kjms.2016.05.008 (2016).","journal-title":"The Kaohsiung journal of medical sciences"},{"key":"61991_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray, R. J. A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk. The Annals of Statistics 16, 1141\u20131154, https:\/\/doi.org\/10.1214\/aos\/1176350951 (1988).","journal-title":"The Annals of Statistics"},{"key":"61991_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2307\/2670170","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P. & Gray, R. J. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J. Am. Stat. Assoc. 94, 496\u2013509, https:\/\/doi.org\/10.2307\/2670170 (1999).","journal-title":"J. Am. Stat. Assoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61991-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:54:55Z","timestamp":1670316895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61991-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61991"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61991-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]},"assertion":[{"value":"12 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.Y. Peng has served as an advisory committee member for AbbVie, Bristol-Myers Squibb, Gilead, and Merck Sharp & Dohme. All other coauthors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5372"}}